Thai woman claims healing powers with quantum psychic energy
A complaint has been raised concerning an individual claiming to be the wife of a deputy governor in…
Pura Collagen enters GLP-1 market with ‘pure’ hormone stimulating alternative
The two innovations expand the startup’s product line to seven, indicating the depth of consideration that goes into…
New weight-loss scams fueled by GLP-1 hype
GLP-1 medications like Ozempic and Wegovy have surged in popularity, but so have scams targeting people eager to…
New weight-loss scams fueled by GLP-1 hype
GLP-1 medications like Ozempic and Wegovy have surged in popularity, but so have scams targeting people eager to…
Jesy Nelson reveals her twins are unlikely to walk after diagnosis
Former Little Mix singer Jesy Nelson has revealed her twin babies are unlikely to ever be able to…
7 medical breakthroughs of 2025
For most diseases, the challenge is not a lack of effort but the limits of existing tools and…
Tamiflu isn’t the only flu treatment available. These other options may fly under the radar – and provide relief
When the flu strikes, it can feel relentless: rising fever, hacking cough, stuffy nose and sore throat. For…
Seasonal Affective Disorder affects millions every year
HATTIESBURG, Miss. (WDAM) – Christmas may be just around the corner, but ‘tis a different kind of season…
International day of persons with disabilities 2025
Every year, on 3 December, the world marks international day of persons with disabilities. In 2025, WHO focuses…
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…